US 12,453,787 B2
Dual mode radiotracer and-therapeutics
Alexander Josef Wurzer, Munich (DE); Hans-Jürgen Wester, Immünster (DE); and Matthias Johannes Eiber, Vaterstetten (DE)
Assigned to Technische Universität München and Technische Universität München—Klinikum Rechts der Isar, Munich (DE)
Filed by Technische Universität München, Munich (DE); and Technische Universität München—Klinikum Rechts der Isar, Munich (DE)
Filed on Nov. 15, 2024, as Appl. No. 18/948,808.
Application 18/948,808 is a continuation of application No. 17/849,297, filed on Jun. 24, 2022, granted, now 12,390,540.
Application 17/849,297 is a continuation of application No. 16/634,759, granted, now 11,413,360, issued on Aug. 16, 2022, previously published as PCT/EP2018/070533, filed on Jul. 30, 2018.
Claims priority of application No. 17183795 (EP), filed on Jul. 28, 2017.
Prior Publication US 2025/0121102 A1, Apr. 17, 2025
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 51/04 (2006.01)
CPC A61K 51/0497 (2013.01) [A61K 51/0402 (2013.01); A61K 51/0482 (2013.01)] 7 Claims
 
1. A compound having a structure according to formula

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt and or individual isomer thereof, optionally containing a chelated radioactive cation.